This product may be reconstituted in water at 2 mg/mL. This is not a sterile product. Stock solutions would require sterile filtration prior to use in cell culture.
Fortfahren mit
SML1988
TASIN-1 hydrochloride
≥98% (HPLC), EBP-dpendent cholesterol synthesis inhibitor, powder
Synonym(e):
1′-(4-Methoxyphenylsulfonyl)-4-methyl-1,4′-bipiperidine hydrochloride, 1,4′-Bipiperidine, 1′-[(4-methoxyphenyl)sulfonyl]-4-methyl-, hydrochloride, Truncated APC Selective INhibitor-1
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
5 mg | Warenkorb auf Verfügbarkeit prüfen | € 103,00 € 87,55 |
25 mg | Warenkorb auf Verfügbarkeit prüfen | € 364,00 € 309,40 |
Über diesen Artikel
Empirische Formel (Hill-System):
C18H28N2O3S · HCl
CAS-Nummer:
Molekulargewicht:
388.95
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated, protect from light
€ 87,55
Listenpreis€ 103,00Sparen Sie 15%Aktion nur im Web
Warenkorb auf Verfügbarkeit prüfen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
TASIN-1 hydrochloride, ≥98% (HPLC)
assay
≥98% (HPLC)
form
powder
storage condition
desiccated, protect from light
color
white to beige
solubility
H2O: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
CC(CC1)CCN1C(CC2)CCN2S(C3=CC=C(OC)C=C3)(=O)=O.[H]Cl
InChI key
TXDTUQPRRXNCLP-UHFFFAOYSA-N
Biochem/physiol Actions
EBP-dependent cholesterol synthesis inhibitor with selective cytotoxicity against colorectal cancer cells harboring APC truncations.
TASIN-1 (Truncated APC Selective INhibitor-1) targets EBP- (Emopamil-binding protein; D8-D7 sterol isomerase) dependent cholesterol biosynthesis and selectively induces cellular cholesterol depletion and apoptotic death in human colorectal cancer (CRC) cultures harboring APC truncations under lipid-deficient conditions (0.2% FCS or 2% lipoprotein-deficient serum; IC50 from 35 nM/HT29 to 4.9 μM/HT55 in 72 hrs) as a result of defective cholesterol homeostasis regulation, while exhibiting little cytotoxicity toward wild-type APC CRC cells or non-transformed human colonic and bronchial epithelial cells (IC50 >50 μM in 72 hrs). TASIN-1 intraperitoneal injection is efficacious against the growth of CRC tumors with trunctated APC using the genetically engineered CPC;Apc mice (20 mg/kg twice a week) and two xenograft murine models (DLD1 & HT29; 40 mg/kg twice daily) without apparent toxicity to the animals.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description ≥98% (HPLC) | description ≥95% (HPLC) | description ≥98% (HPLC) | description ~99% (HPLC), powder |
| form powder | form powder | form powder | form powder |
| assay ≥98% (HPLC) | assay ≥95% (HPLC) | assay ≥98% (HPLC) | assay ~99% (HPLC) |
| storage temp. 2-8°C | storage temp. room temp | storage temp. 2-8°C | storage temp. - |
| storage condition desiccated, protect from light | storage condition desiccated | storage condition - | storage condition - |
| solubility H2O: 2 mg/mL, clear | solubility H2O: 2 mg/mL, clear (warmed) | solubility H2O: 1 mg/mL, clear (warmed) | solubility H2O: >2.0 mg/mL |
| color white to beige | color white to beige | color white to beige | color white |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
How is it recommended to reconstitute Tasin-1 (solvent and up to what concentration)? And does it need to be filter sterilised before use in cell-culture?
1 answer-
Helpful?
-